Arabic Arabic English English French French German German
dark

Hillstream BioPharma Expands the Scientific Advisory Board with the Addition of Leading Innovator in the Study of Ferroptosis and Cancer, Scott Dixon, Ph.D.

Hillstream BioPharma, Inc. today announced the expansion of the Scientific Advisory Board (SAB) with the addition of Scott J. Dixon, Ph.D. , Associate Professor, Biology, Stanford University. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Artax Biopharma Granted MHRA Clinical Trial Authorization for AX-158

Next Post

Ascletis Announces Dosing of the First Cohort of Healthy Subjects in the FXR Agonist ASC42 Bridging Study for Chronic Hepatitis B Indication in China

Related Posts
Total
0
Share